Istituto Nazionale Tumori Fondazione Pascale - IRCCS · S.C. Oncologia Medica Melanoma, Immunoterapia Oncologica e Terapie Innovative

Naples 80131

0 studies enrolling now · 1 studies all time

What they study most

Melanoma Stage III, Melanoma Stage IV, Unresectable Melanoma

Studies at this site

• A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment — Completed